KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Payables (2009 - 2026)

Johnson & Johnson recorded quarterly Payables of $27.9 billion in Q1 2026, up 36.29% quarter-over-quarter from $20.5 billion in Q4 2025, and up 19.1% year-over-year from $23.4 billion in Q1 2025.

Johnson & Johnson's Payables history runs 18 years deep, the most recent figure standing at $27.9 billion for Q1 2026.

  • In Q1 2026, Payables rose 19.1% year-over-year to $27.9 billion; the TTM figure through Mar 2026 stood at $27.9 billion (up 19.1% YoY), while the FY2025 annual figure was $20.5 billion, up 25.73% from the prior year.
  • Payables came in at $27.9 billion for Q1 2026 at Johnson & Johnson, up from $20.5 billion in the prior quarter.
  • In the past five years, Payables ranged from a high of $27.9 billion in Q1 2026 to a low of $12.2 billion in Q4 2023.
  • A 5-year average of $18.3 billion and a median of $16.5 billion in 2024 frame the typical range for Payables.
  • On a YoY basis, Payables climbed as much as 104.97% in 2023 and fell as far as 42.23% in 2023.
  • Johnson & Johnson's Payables stood at $14.6 billion in 2022, then decreased by 10.25% to $13.1 billion in 2023, then increased by 24.54% to $16.3 billion in 2024, then rose by 25.73% to $20.5 billion in 2025, then surged by 36.29% to $27.9 billion in 2026.
  • According to Business Quant data, Payables over the past three periods registered $27.9 billion, $20.5 billion, and $16.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 5.03 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 27.92 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 33.77 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 6.01 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 2.94 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 645.00 Mn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 4.51 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 4.23 Bn
10 Gsk 88.34 Bn 83.66 Bn - 24.45 Bn

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 27.92 Bn
Dec 28, 2025 20.49 Bn
Sep 28, 2025 16.01 Bn
Jun 29, 2025 20.99 Bn
Mar 30, 2025 23.44 Bn
Dec 29, 2024 16.29 Bn
Sep 29, 2024 13.42 Bn
Jun 30, 2024 18.70 Bn
Mar 31, 2024 16.72 Bn
Dec 31, 2023 13.08 Bn
Oct 1, 2023 12.23 Bn
Jul 2, 2023 22.14 Bn
Apr 2, 2023 27.89 Bn
Jan 1, 2023 22.65 Bn
Oct 2, 2022 14.58 Bn
Jul 3, 2022 14.07 Bn
Apr 3, 2022 13.61 Bn
Jan 2, 2022 14.82 Bn
Oct 3, 2021 12.76 Bn
Jul 4, 2021 11.88 Bn
Apr 4, 2021 11.85 Bn
Jan 3, 2021 12.14 Bn
Sep 27, 2020 12.12 Bn
Jun 28, 2020 12.10 Bn
Mar 29, 2020 9.60 Bn
Dec 29, 2019 9.75 Bn
Sep 29, 2019 9.79 Bn
Jun 30, 2019 8.63 Bn
Mar 31, 2019 8.63 Bn
Dec 30, 2018 10.33 Bn
Sep 30, 2018 8.77 Bn
Jul 1, 2018 9.19 Bn
Apr 1, 2018 9.14 Bn
Dec 31, 2017 11.22 Bn
Oct 1, 2017 14.88 Bn
Jul 2, 2017 13.34 Bn
Apr 2, 2017 11.44 Bn
Jan 1, 2017 11.60 Bn
Oct 2, 2016 9.41 Bn
Jul 3, 2016 7.77 Bn
Apr 3, 2016 9.08 Bn
Jan 3, 2016 13.67 Bn
Sep 27, 2015 11.61 Bn
Jun 28, 2015 11.36 Bn
Mar 29, 2015 10.76 Bn
Dec 28, 2014 11.27 Bn
Sep 28, 2014 8.72 Bn
Jun 29, 2014 10.01 Bn
Mar 30, 2014 10.06 Bn
Dec 29, 2013 11.12 Bn
Sep 29, 2013 11.41 Bn
Jun 30, 2013 11.03 Bn
Mar 31, 2013 9.90 Bn
Dec 30, 2012 10.51 Bn
Sep 30, 2012 10.77 Bn
Jul 1, 2012 11.19 Bn
Apr 1, 2012 11.52 Bn
Jan 1, 2012 12.38 Bn
Oct 2, 2011 11.06 Bn
Jul 3, 2011 10.74 Bn
Apr 3, 2011 14.28 Bn
Jan 2, 2011 13.24 Bn
Oct 3, 2010 8.32 Bn
Jul 4, 2010 8.59 Bn
Apr 4, 2010 9.17 Bn
Jan 3, 2010 11.86 Bn
Sep 27, 2009 9.76 Bn
Jun 28, 2009 11.27 Bn